| Financial Year |
March 31 2023 |
| Monetary Funds |
755,649,053.21 |
| Held-for-trading Financial Assets |
2,275,346.21 |
| Notes Receivable |
-- |
| Accounts Receivable |
602,736,232.51 |
| Advances to Suppliers |
104,700,097.07 |
| Other Receivables |
160,546,420.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,527,500.00 |
| Dividend Receivable |
-- |
| Inventories |
1,193,420,163.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
419,063,687.90 |
| Total Current Assets |
3,993,850,029.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,379,927.35 |
| Long-term Equity Investment |
26,139,229.97 |
| Investment Properties |
-- |
| Fixed Assetes |
1,832,460,991.32 |
| Under-construction Projects |
143,525,428.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
333,372,031.48 |
| R&D expenses |
-- |
| Goodwill |
50,076,410.61 |
| Long-Term Deferred and Prepaid Expenses |
127,530,624.59 |
| Deferred Income Tax Assets |
131,463,652.08 |
| Other Non-Current Assets |
218,498,567.65 |
| Sub-Total of Non-Current Assets |
2,872,781,189.50 |
| Total Assets |
6,866,631,219.31 |
| Short-Term Loans |
444,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
873,966,641.53 |
| Accounts Payable |
562,958,024.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,859,975.06 |
| Taxes Payable |
105,756,789.27 |
| Interest Payable |
-- |
| Dividend Payable |
3,410,305.86 |
| Other payables |
109,591,888.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
143,885,114.29 |
| Other Current Liabilities |
17,867,828.26 |
| Sub-Total of Current Liabilities |
2,441,436,577.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,776,926.93 |
| Deferred Income Tax Liabilities |
14,357,256.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
76,563,954.73 |
| Total Liabilities |
2,518,000,532.11 |
| Paid-In Capital(Or Share Stock) |
1,706,325,581.00 |
| Capital Surplus |
3,778,669,304.35 |
| Surplus Reserve |
53,707,906.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,224,304,061.49 |
| Minority Stockholder's Interest |
32,415,425.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,316,215,261.84 |
| Owner's Equity（Stockholder's Equity） |
4,348,630,687.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,866,631,219.31 |
